James Forsyth is a Director in Deloitte’s Life Sciences & Healthcare Strategy practice based in London. James has over 11 years of experience working with Life Sciences companies. He is a leader Deloitte’s European Life Sciences Center of Excellence on Launch and Value.
James has launched globally, next generation drugs primarily focused on oncology and metabolic disorders. For these launches, he has partnered with the companies to support both launches usually starting from T-24 or T-18 months and end of patent strategies. His support ranges from the overall commercial strategy, the market access and pricing strategy to the creation of the RWE and value-added solutions to support the launch.